Reference number : 236-2011-2012-Q1-00428, amendment number : , agreement type : G, recipient legal name : GLEASON, James L, recipient country : CA, recipient province : QC, recipient city : Montreal, recipient postal code : H3A 2T5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 354884.0, agreement start date : 2011-10-01, agreement end date : 2014-09-30, description english : Novel bivalent hybrid molecules with retinoic acid receptor agonistic and histone deacetylase inhibitory activity for cancer treatment, description french : Novel bivalent hybrid molecules with retinoic acid receptor agonistic and histone deacetylase inhibitory activity for cancer treatment, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2011-12 to 2014-15), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2011-12 à 2014-15), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada